Cynthia A Oksanen

Title: The Innovative Contributions of Cynthia A Oksanen

Introduction

Cynthia A Oksanen is a notable inventor based in Stonington, CT (US). She has made significant contributions to the field of pharmaceuticals, particularly in the development of combination dosage forms. With a total of 2 patents to her name, her work has had a meaningful impact on medication delivery systems.

Latest Patents

Cynthia's latest patents include a combination dosage form comprising cetirizine and pseudoephedrine. This innovative dosage form contains cetirizine as an immediate release component and pseudoephedrine or a pharmaceutically acceptable salt thereof as a controlled release component. Notably, a portion of the pseudoephedrine can also be incorporated as an immediate release component. Furthermore, the dosage form is free of alcohols having a molecular weight lower than 100 and reactive derivatives thereof.

Career Highlights

Cynthia A Oksanen is currently associated with Pfizer Corporation, a leading global pharmaceutical company. Her work at Pfizer has allowed her to focus on developing advanced pharmaceutical formulations that enhance patient care and treatment efficacy.

Collaborations

Cynthia has collaborated with several esteemed colleagues, including Barbara A Johnson and Richard W Korsmeyer. These collaborations have fostered a productive environment for innovation and research within the pharmaceutical sector.

Conclusion

Cynthia A Oksanen's contributions to the field of pharmaceuticals through her patents and work at Pfizer Corporation highlight her role as an influential inventor. Her innovative approaches to medication formulation continue to advance the industry and improve patient outcomes.